{
    "Trade/Device Name(s)": [
        "Sysmex CS-2100i"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Products GmbH",
    "510(k) Number": "K161312",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011235"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPA"
    ],
    "Summary Letter Date": "July 28, 2016",
    "Summary Letter Received Date": "August 1, 2016",
    "Submission Date": "August 26, 2016",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin Time (PT)",
        "PT INR",
        "Activated Partial Thromboplastin Time (APTT)",
        "Fibrinogen (Fbg)",
        "Antithrombin (AT)",
        "D-dimer"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "3.2% sodium citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Sysmex CS-2100i"
    ],
    "Method(s)/Technology(ies)": [
        "Clotting",
        "Chromogenic",
        "Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument"
    ],
    "Document Summary": "FDA 510(k) summary for Sysmex CS-2100i automated blood coagulation analyzer with expanded use of INNOVANCE D-Dimer for exclusion of deep vein thrombosis.",
    "Indications for Use Summary": "Fully automated blood coagulation analyzer for in vitro diagnostic use with plasma from venous blood collected in sodium citrate tubes to analyze clotting, chromogenic and immunoassay methods in the clinical laboratory for PT, APTT, fibrinogen, antithrombin, and D-dimer.",
    "fda_folder": "Hematology"
}